-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
A Case from Shijiazhuang Sihua Pharmaceutical Selected for Inclusion in the MIIT’s Public List of “Digital Three Products” Application Scenario Cases
Category:
发布时间：2024-12-24
【概要描述】
Recently, the Ministry of Industry and Information Technology released the public list of typical application cases for the 2024 “Digital Three Products” initiative. Among ten specific application scenarios, the “Innovative Application of an Intelligent Operation and Collaborative Scheduling Platform for Injectable Pharmaceuticals” submitted by Shijiazhuang Sihua Pharmaceutical Co., Ltd. was selected as a case of intelligent scheduling and production planning geared toward lean management.
Recently, the Ministry of Industry and Information Technology released the public list of typical application cases for the 2024 “Digital Three Products” initiative. Among ten specific application scenarios, the “Innovative Application of an Intelligent Operation and Collaborative Scheduling Platform for Injectable Pharmaceuticals” submitted by Shijiazhuang Sihua Pharmaceutical Co., Ltd. was selected as a case of intelligent scheduling and production planning geared toward lean management.
As a leading domestic manufacturer of injectable pharmaceuticals, Shijiazhuang Sihua Pharmaceutical boasts a diverse product portfolio, substantial production capacity, and strong market demand. By leveraging information technology, the company continuously enhances the collaborative efficiency of its core product manufacturing operations. The “Innovative Application of an Intelligent Operations Coordination and Dispatch Platform for Pharmaceuticals” is a resource-optimization platform built on knowledge bases, modeling, optimization algorithms, and simulation. Through lean digital management, the platform continually explores new application methods and use cases. In response to evolving industrial operations and market demands, it systematically models business processes across the entire value chain—production, supply, and sales—effectively establishing seamless information flows from customer requirements to key operational functions such as production, procurement, warehousing, and R&D. This supports the company in accelerating its market responsiveness, shortening product delivery times, and enhancing flexible manufacturing capabilities, thereby consistently delivering products and services with shorter lead times, lower costs, and higher quality to customers. Since its implementation, this application has demonstrated strong innovation and practical value, serving as a compelling industry benchmark.
According to reports, the Ministry of Industry and Information Technology has launched a call for exemplary application cases under the “Digital Three-Product” initiative, with a focus on three key areas—expanding product variety, enhancing product quality, and building strong brands—and concentrating on critical links such as R&D and design, production and manufacturing, business management, and customer service, thereby selecting a number of cases that demonstrate the integrated application of digital and intelligent technologies.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091